Session 8 of Obesity Management is led by Dr. Anshu Gupta. See bottom of description for accreditation info. This ECHO session explores the role of pharmacotherapy in the management of adolescent obesity. The session reviews the prevalence of pediatric obesity, highlights key guidance from the AAP pediatric obesity guidelines, and explores how anti-obesity medications can be […]
Session 10 of Obesity Management is led by Mary Lou Perry. See bottom of description for accreditation info. This ECHO session examines the growing popularity and clinical evidence behind intermittent fasting, particularly time-restricted eating (TRE). The session defines intermittent fasting and TRE, reviews key research findings, and compares time-restricted eating with continuous energy restriction approaches […]
Session 9 of Obesity Management is led by Dr. Jennifer Kirby. See bottom of description for accreditation info. This ECHO session focuses on understanding and managing the side effects associated with anti-obesity medications. The session reviews common gastrointestinal and non-gastrointestinal side effects patients may experience, including those related to incretin-based therapies, phentermine, and the bupropion/naltrexone […]
Session 2 of EMS Endocrine Management is led by Dr. Bill Brady. This ECHO session reviews endocrine emergencies including adrenal crisis, thyroid storm, myxedema coma, and pheochromocytoma–related hypertensive emergencies. Participants will explore underlying pathophysiology, including corticosteroid and thyroid hormone function, common causes and risk factors, clinical presentation, differential diagnosis, and evidence-based acute management strategies. Through […]
Session 1 of EMS Endocrine Management is led by Dr. George Lindbeck. This ECHO session introduces diabetes, starting with the basics of what it is, the different types, and how glucose and insulin work in the body. It reviews the importance of hemoglobin A1c, the prevalence of diabetes, and its broad impact on patients’ overall […]
